James M. Ahlers

Chief Financial Officer, RenovoRx, Inc.

Companies

Cue Biopharma, Inc.Chief financial officer Aug 3, 2026 to now¹
INTENSITY THERAPEUTICS, INC.Executive VP of CF Jun 29, 2023 to Jun 29, 2023²
RenovoRx, Inc.Chief financial officer Jul 20, 2022 to Jul 20, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cue Biopharma, Inc. CUE25,500 shares⁴$428.7K at $16.81Jul 30, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 30, 2026Granted 25,500 shares of Cue Biopharma, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCue Biopharma, Inc., Chief financial officer
2
SEC EDGARINTENSITY THERAPEUTICS, INC., Executive VP of CF
3
SEC EDGARRenovoRx, Inc., Chief financial officer
4
SEC EDGARCue Biopharma, Inc. shares after the filing of Jul 30, 2026